Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUT058-60 cumulative skin irritation study
NCT02198963Phase 1Completed
- Sponsor
- Pulmatrix, Inc.
- Start
- Jul 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of RUT058-60 in skin infection (SSTI) (3 arms), sponsored by Pulmatrix, Inc. Primary endpoint: Cumulative Irritation Score at 21 days. Started Jul 2014; status: completed.
02
Drugs
RUT058-60
03
Conditions
skin infection (SSTI)
Beyond the preview
Go deeper on NCT02198963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198963.